HBM Healthcare Investments continued its impressive growth in net assets in the third quarter of the 2020/2021 financial year. Thanks to a quarterly profit of CHF 203 million with contributions from all portfolio categories, the result for the first nine months rose to CHF 645 million. The highlights included five IPOs and one sale from the portfol [ … ]

 in CHFPerformance in % 15.01.2021MTDFYTDCYTDNAVCHF 302.913.349.23.3Share PriceCHF 304.00-0.364.1-0.3Total Net Assets (in million)2'107    MTD      Month to DateFYTD     Financial Year to Date (since 1.4.2020)CYTD    Calendar Year to Date (since 1.1.2021) End of ad hoc announcement Language: English Company: HBM Healthcare Investments AG Bunde [ … ]

HBM Healthcare Investments closed the volatile 2020 calendar year, marked by the uncertainties surrounding the Covid-19 pandemic, with an outstanding result. Net asset value per share (NAV) rose by a high 36.7 percent to CHF 293.21 as at 31 December 2020, while the share price increased by 40.5 percent to close at CHF 305.00 with a small premium to [ … ]

 in CHFPerformance in % 31.12.2020MTDFYTDCYTDNAVCHF 293.211.844.536.7Share PriceCHF 305.006.864.640.5Total Net Assets (in million)2'040    MTD      Month to DateFYTD     Financial Year to Date (since 1.4.2020)CYTD    Calendar Year to Date (since 1.1.2020) End of ad hoc announcement Language: English Company: HBM Healthcare Investments AG Bunde [ … ]

EQS Group-News: HBM Healthcare Investments AG / Key word(s): IPO IPOs of Bioatla and Seer boost HBM Healthcare Investments' net asset value per share 17.12.2020 / 06:50 With Bioatla (Nasdaq: BCAB), another private company from the HBM Healthcare Investments portfolio successfully went public yesterday. The company placed 10.5 mi [ … ]